Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

Published:2018-04-17 Issue:12 Volume:47 Page:1682-1689
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Anty R.¹,Favre G.¹^ORCID,Coilly A.²,Rossignol E.³,Houssel-Debry P.³,Duvoux C.⁴,De Ledinghen V.⁵^ORCID,Di Martino V.⁶,Leroy V.⁷,Radenne S.⁸,Kamar N.⁹,Canva V.¹⁰,D'Alteroche L.¹¹,Durand F.¹²,Dumortier J.⁸^ORCID,Lebray P.¹³,Besch C.¹⁴,Tran A.¹,Canivet C. M.¹,Botta-Fridlund D.¹⁵,Montialoux H.¹⁶,Moreno C.¹⁷,Conti F.¹³,Silvain C.¹⁸,Perré P.¹⁹,Habersetzer F.¹⁴,Abergel A.²⁰,Debette-Gratien M.²¹,Dharancy S.¹⁰,Esnault V. L. M.²,Fougerou-Leurent C.³,Cagnot C.¹²,Diallo A.²²,Veislinger A.³,Danjou H.³,Samuel D.²,Pageaux G.-P.²²^ORCID,Duclos-Vallée J.-C.²,

Affiliation:

1. Nice France

2. Villejuif France

3. Rennes France

4. Créteil France

5. Bordeaux France

6. Besançon France

7. Grenoble France

8. Lyon France

9. Toulouse France

10. Lille France

11. Tours France

12. Clichy France

13. Paris France

14. Strasbourg France

15. Marseille France

16. Rouen France

17. Belgique France

18. Poitiers France

19. La Roche sur Yon France

20. Clermont-Ferrand France

21. Limoges France

22. Montpellier France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14639/fullpdf

Reference33 articles.

1. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study;Coilly;J Hepatol,2016

2. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: real-world experience from the hepatitis C therapeutic registry and research network;Brown;Liver Transpl,2016

3. Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience;Jackson;Clin Transplant,2016

4. Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation;Ciesek;Transpl Infect Dis,2016

5. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation;Charlton;Gastroenterology,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil gelatinase-associated lipocalin partly reflects the dynamic changes of renal function among chronic hepatitis C patients receiving direct-acting antivirals;PLOS ONE;2021-08-26

2. Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals;Journal of Hepatology;2020-05

3. Liver Disease and Chronic Kidney Disease;Chronic Renal Disease;2020

4. Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register);European Journal of Gastroenterology & Hepatology;2019-11

5. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence;Transplant Infectious Disease;2018-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3